HSBC acquisition of SVB UK to unleash new opportunities in biotech sector, finds GlobalData
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
SVB Financial Group and its subsidiaries were involved in over $1.4 billion in total venture financing raised from 2010 to 2022 for drug development
The agreement will facilitate the establishment of the IITK-UB Joint Center of Excellence in Biomedicine and Bioengineering
This initiative encapsulates the essence of OPPI’s commitment towards enabling a healthier India
This new capability represents a significant shift from a microscope-based standard of care to the use of digital whole slide images
Nearly 5000 executives and more than 350 exhibitors turned out at the largest post-pandemic pharma packaging event
The company's consolidated revenues for the quarter grew 36% to Rs. 3,020 crore on the back of robust performance across all its three businesses
The Innovation Explorer database of GlobalData’s Disruptor Intelligence Center highlights the key company collaborations in pharma to advance AI-powered drug repurposing techniques.
It dwells on colocating 157 nursing colleges with medical colleges and eliminating sickle cell anaemia by 2047
The company is pleased to report positive performances from all divisions this quarter. Growth in our research divisions, Discovery Services and the Dedicated Centres was solid
Multilateral collaborations will serve to strengthen knowledge sharing to formulate framework for accessible, affordable, and quality healthcare
Subscribe To Our Newsletter & Stay Updated